FindTrial
Sign In

Effect of local 0.5% lidocaine injection in the prevention of acute postoperative pain associated with breast surgery

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-521162-10-00
Enrollment
128
Registered
2025-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disminuir dolor en cirugía de mama

Brief summary

Dolor agudo postoperatorio a la 1, 4, 12, 24 y 48h postoperatorias (escala EVA), en reposo y en movimiento con la abducción del brazo > 90º

Interventions

DRUGLidoject 1 % Injektionslösung

Sponsors

Consorci Sanitari Integral
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Dolor agudo postoperatorio a la 1, 4, 12, 24 y 48h postoperatorias (escala EVA), en reposo y en movimiento con la abducción del brazo > 90º—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026